blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0699236

EP0699236 - PURIFIED MAMMALIAN FLT3 LIGANDS AND AGONISTS AND ANTAGONISTS THEREOF [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  12.05.2006
Database last updated on 11.04.2026
Most recent event   Tooltip12.05.2006Patent maintained (B2 publication)published on 14.06.2006  [2006/24]
Applicant(s)For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75643 Paris Cédex 13 / FR
[N/P]
Former [2006/24]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road Kenilworth
New Jersey 07033 / US
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75643 Paris Cédex 13 / FR
Former [2000/40]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road
Kenilworth New Jersey 07033 / US
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
75643 Paris Cédex 13 / FR
Former [1996/10]For all designated states
SCHERING CORPORATION
2000 Galloping Hill Road
Kenilworth New Jersey 07033 / US
For all designated states
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
101, rue de Tolbiac
F-75643 Paris Cédex 13 / FR
Inventor(s)01 / HANNUM, Charles, H.
1081 Westchester Drive
Sunnyvale, CA 94087 / US
02 / LEE, Frank, D.
620 Lowell Avenue
Palo Alto, CA 94301 / US
03 / BIRNBAUM, Daniel
9, rue Baldacchini, La Croix-du-Sud
F-13009 Marseille / FR
04 / CULPEPPER, Janice, A.
1755 Ednamary Way 2
Mountain View, CA 94040 / US
[1996/10]
Representative(s)Adams, Harvey Vaughan John, et al
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2005/17]Adams, Harvey Vaughan John, et al
Mathys & Squire, 120 Holborn
London EC1N 2SQ / GB
Former [2004/45]Taylor, Kathryn May
Mathys & Squire, 100 Gray's Inn Road
London WC1X 8AL / GB
Former [1996/10]Ritter, Stephen David, et al
Mathys & Squire 100 Grays Inn Road
London WC1X 8AL / GB
Application number, filing date94919120.918.05.1994
[1996/10]
WO1994US05150
Priority number, dateUS1993006523119.05.1993         Original published format: US 65231
US1993008926307.07.1993         Original published format: US 89263
US1993009254916.07.1993         Original published format: US 92549
US1993010634013.08.1993         Original published format: US 106340
US1993011239124.08.1993         Original published format: US 112391
US1993015511119.11.1993         Original published format: US 155111
US1993016241303.12.1993         Original published format: US 162413
[1996/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9426891
Date:24.11.1994
[1994/26]
Type: A1 Application with search report 
No.:EP0699236
Date:06.03.1996
Language:EN
The application published by WIPO in one of the EPO official languages on 24.11.1994 takes the place of the publication of the European patent application.
[1996/10]
Type: B1 Patent specification 
No.:EP0699236
Date:04.10.2000
Language:EN
[2000/40]
Type: B2 New European patent specification 
No.:EP0699236
Date:14.06.2006
Language:EN
[2006/24]
Search report(s)International search report - published on:EP19.01.1995
ClassificationIPC:C12N15/12, C12P21/02, C07K14/475, C12P21/08, A61K38/18, G01N33/68, C12N1/21, C12N5/10, A61K39/00, C12Q1/68
[1999/42]
CPC:
C07K14/475 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P13/02 (EP); A61P15/00 (EP); A61P25/00 (EP);
A61P35/00 (EP); A61P9/00 (EP); A61K38/00 (EP) (-)
Former IPC [1996/10]C12N15/12, C12P21/02, C07K13/00, C12P21/08, A61K37/02, G01N33/68, C12N1/21, C12N5/10, A61K39/00, C12Q1/68
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1996/10]
TitleGerman:GEREINIGTE FLT3 LIGANDEN VON SAEUGENTIEREN, AGONISTEN UND ANTAGONISTEN DAVON[1999/44]
English:PURIFIED MAMMALIAN FLT3 LIGANDS AND AGONISTS AND ANTAGONISTS THEREOF[1996/10]
French:LIGANDS PURIFIES DE FLT3 DE MAMMIFERES ET LEURS AGONISTES/ANTAGONISTES[1996/10]
Former [1996/10]GEREINIGTE SAUEGETIERE FLT3 LIGANDE, AGONISTE UND ANTAGONISTE DAVON
Entry into regional phase29.09.1995National basic fee paid 
29.09.1995Designation fee(s) paid 
29.09.1995Examination fee paid 
Examination procedure28.11.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.09.1995Examination requested  [1996/10]
18.03.1996Despatch of a communication from the examining division (Time limit: M06)
19.09.1996Reply to a communication from the examining division
04.07.1997Despatch of a communication from the examining division (Time limit: M08)
22.01.1998Reply to a communication from the examining division
23.10.1998Despatch of a communication from the examining division (Time limit: M04)
17.12.1998Reply to a communication from the examining division
02.03.1999Despatch of a communication from the examining division (Time limit: M04)
01.07.1999Reply to a communication from the examining division
27.09.1999Despatch of communication of intention to grant (Approval: Yes)
07.02.2000Communication of intention to grant the patent
25.04.2000Fee for grant paid
25.04.2000Fee for publishing/printing paid
Divisional application(s)EP99116598.6  / EP0992584
Opposition(s)Opponent(s)01  29.06.2001  12.07.2001  ADMISSIBLE
Immunex Corporation
51 University Street
Seattle, Washington 98101 / US
Opponent's representative
Cornish, Kristina Victoria Joy
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
 [N/P]
Former [2002/46]
Opponent(s)01  29.06.2001  12.07.2001  ADMISSIBLE
Immunex Corporation
51 University Street
Seattle, Washington 98101 / US
Opponent's representative
Cornish, Kristina Victoria Joy
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Former [2001/34]
Opponent(s)01  29.06.2001  12.07.2001  ADMISSIBLE
Immunex Corporation
51 University Street
Seattle, Washington 98101 / US
Opponent's representative
Keller, Günter, Dr.
Lederer, Keller & Riederer Patentanwälte Prinzregentenstrasse 16
80538 München / DE
21.08.2001Invitation to proprietor to file observations on the notice of opposition
30.04.2002Reply of patent proprietor to notice(s) of opposition
16.09.2003Date of oral proceedings
31.10.2003Despatch of minutes of oral proceedings
16.03.2005Despatch of interlocutory decision in opposition
16.03.2005Legal effect of interlocutory decision in opposition
16.09.2005Despatch of communication that the patent will be maintained as amended
19.12.2005Fee for printing new specification paid
Appeal following opposition30.12.2003Appeal received No.  T0020/04
27.02.2004Statement of grounds filed
16.03.2005Result of appeal procedure: maintenance in amended form
16.03.2005Date of oral proceedings
22.03.2005Minutes of the oral proceedings despatched
Fees paidRenewal fee
17.04.1996Renewal fee patent year 03
16.04.1997Renewal fee patent year 04
20.04.1998Renewal fee patent year 05
14.04.1999Renewal fee patent year 06
17.04.2000Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.10.2000
BE04.10.2000
CH04.10.2000
GR04.10.2000
LI04.10.2000
NL04.10.2000
DK04.01.2001
PT04.01.2001
SE04.01.2001
IE18.05.2001
LU18.05.2001
[2004/39]
Former [2004/07]AT04.10.2000
BE04.10.2000
CH04.10.2000
GR04.10.2000
LI04.10.2000
NL04.10.2000
DK04.01.2001
PT04.01.2001
SE04.01.2001
IE18.05.2001
Former [2003/45]AT04.10.2000
BE04.10.2000
CH04.10.2000
LI04.10.2000
NL04.10.2000
DK04.01.2001
PT04.01.2001
SE04.01.2001
IE18.05.2001
Former [2003/08]AT04.10.2000
BE04.10.2000
CH04.10.2000
LI04.10.2000
NL04.10.2000
PT04.01.2001
SE04.01.2001
IE18.05.2001
Former [2002/48]AT04.10.2000
BE04.10.2000
CH04.10.2000
LI04.10.2000
PT04.01.2001
SE04.01.2001
IE18.05.2001
Former [2002/11]AT04.10.2000
BE04.10.2000
CH04.10.2000
LI04.10.2000
PT04.01.2001
SE04.01.2001
Former [2002/10]AT04.10.2000
BE04.10.2000
CH04.10.2000
LI04.10.2000
SE04.01.2001
Former [2002/02]AT04.10.2000
BE04.10.2000
SE04.01.2001
Former [2001/51]AT04.10.2000
SE04.01.2001
Former [2001/37]AT04.10.2000
Cited inInternational search[PX]   HANNUM ET AL.: "Ligand for Flt3/Flk2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs", NATURE, vol. 368, no. 6472, 14 April 1994 (1994-04-14), pages 643 - 648 [PX] 1-5,7,8,10 * the whole document *
 [PX]   LYMAN ET AL.: "Cloning of the human homolog of the murine flt3 ligand : a growth factor for early haematopoietic progenitor cells", BLOOD, vol. 83, no. 10, 15 May 1994 (1994-05-15), pages 2795 - 2801 [PX] 1-5,7,8,10 * the whole document *
 [PX]   LYMAN ET AL.: "Molecular cloning of a ligand for the Flt3/Flk-2 tyrosine kinase receptor : a proliferative factor for primitive haematopoietic cells", CELL, vol. 75, no. 6, 17 December 1993 (1993-12-17), pages 1157 - 1167 [PX] 1-8,10,11
 [AD]   ROSNET ET AL.: "Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family", ONCOGENE, vol. 6, no. 9, September 1991 (1991-09-01), pages 1641 - 1650 [AD] 1-8,10,11
 [AD]   MATTHEWS ET AL.: "A receptor Tyrosine kinase specific to haematopoietic stem and progenitor cell-enriched populations", CELL, vol. 65, 28 June 1991 (1991-06-28), pages 1143 - 1152 [AD] 1-8,10,11
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.